Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies.

J Cancer Res Clin Oncol · 2023 · PMC10356883 · PMID 36689060

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The SMI was significantly lower in patients who died within the first 12 or 24 months after TACE and showed a trend toward lower values in patients who died within 6 months compared to surviving patients, respectively (Fig. 4 A–C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.